Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers

Vaccine

Volumn 27, Issue 4, 2009, Pages 592-596

  Le Gros, F X ^a   Dancer, A ^a   Giacomini, C ^a   Pizzoni, L ^a   Bublot, M ^a   Graziani, M ^b   Prandini, F ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b Merial Italia spa ^*  (Italy)

Author keywords

Avian diseases; In ovo vaccination; Infectious bursal disease; Maternal antibodies interference; Vaccine efficacy; Vector vaccine

Indexed keywords

TURKEY HERPES VIRUS INFECTIOUS BURSAL DISEASE VECTOR VACCINE; UNCLASSIFIED DRUG; VAXXITEK; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BIRD DISEASE; BURSA FABRICII; CHICK; CONTROLLED STUDY; FIELD STUDY; HERPES VIRUS; IMMUNOGENICITY; INFECTIOUS BURSAL DISEASE; INFECTIOUS BURSAL DISEASE VIRUS; NONHUMAN; PRIORITY JOURNAL; REOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BIRNAVIRIDAE INFECTIONS; CHICKENS; INFECTIOUS BURSAL DISEASE VIRUS; POULTRY DISEASES; VACCINATION; VIRAL VACCINES;

EID: 57849151951     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.094     Document Type: Article

References (12)

1. van den Berg T., Eterradossi N., Toquin D., and Meulemans G. Infectious bursal disease (Gumboro disease). Rev Sci Tech 19 August (2) (2000) 509-543
2. Rautenschlein S., Kraemer C., Vanmarcke J., and Montiel E. Protective efficacy of intermediate and intermediate plus infectious bursal disease virus (IBDV) vaccines against very virulent IBDV in commercial broilers. Avian Dis 49 (2005) 231-237
3. Darteil R., Bublot M., Laplace E., Bouquet J.F., Audonnet J.C., and Riviere M. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211 (1995) 481-490
4. Goutebroze S., Curet M., Jay M.L., Roux C., and Le Gros F.X. Efficacy of a recombinant HVT-VP2 against Gumboro disease in the presence of maternal antibodies. Br Poultr Sci 44 (2003) 824-825
5. Morgan R.W., Gelb Jr. J., Schreurs C.S., Lutticken D., Rosenberger J.K., and Sondermeijer P.J. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis 36 (1992) 858-870
6. Martin A., Fallacara M., Barbieri F., Tosi G., Rivallan G., Eterradossi N., et al. Genetic and antigenic characterization of infectious bursal disease viruses isolated in Italy during the period 2002-2005. Avian Dis 51 4 (2007) 863-872
7. Kusk M., Kabell S., Jørgensen P.H., and Handberg K.J. Differentiation of five strains of infectious bursal disease virus: development of a strain-specific multiplex PCR. Vet Microbiol 109 3-4 (2005) 159-167
8. Lamichhane C.M., Kirkegaard L., and Collins W. ELISA provides better detection of antibodies to infectious bursal disease virus (IBDV). Proceedings XI the international congress of the world veterinary poultry association. Budapest, Hungary 18-22 August (1997) 41
9. Coulibaly F., Chevalier C., Gutsche I., Pous J., Navaza J., Bressanelli S., et al. The Birnavirus cristal structure reveals structural relationship among iscosahedral viruses. Cell 120 March (2005) 761-772
10. Le Gros F.X., Goutebroze S., and Bublot M. Efficacy of and HVT/VP2 vectored vaccine against vvIBD challenge after in ovo injection in presence of IBD maternal antibodies. Proceedings of the 14th world veterinary poultry congress. Istanbul (2005) 279
11. Bublot M., Pritchard N., Le Gros F.X., and Goutebroze S. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titrated maternal derived antibody. J Comp Path 137 (2007) S81-S84
12. Tsukamoto K., Saito S., Saeki S., Tanimura N., Isobe T., Mase M., et al. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J Virol 76 (2002) 5637-5645